Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Merchant

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 25, 2010
Preclinical absorption, distribution, metabolism, excretion, and pharmacokinetic-pharmacodynamic modelling of N-(4-(3-((3S,4R)-1-ethyl-3-fluoropiperidine-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-4-yloxy)-3-fluorophenyl)-2-(4-fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxamide, a novel MET kinase inhibitorBianca M Liederer, Leonid M Berezhkovskiy, Brian J Dean, et al.
NPJ Systems Biology and Applications|September 8, 2017
Erratum: Clinical responses to ERK inhibition in <i>BRAF</i><sup>V600E</sup>-mutant colorectal cancer predicted using a computational modelDaniel C Kirouac, Gabriele Schaefer, Jocelyn Chan, et al.
NPJ Systems Biology and Applications|June 27, 2017
Clinical responses to ERK inhibition in <i>BRAF</i><sup>V600E</sup>-mutant colorectal cancer predicted using a computational modelDaniel C Kirouac, Gabriele Schaefer, Jocelyn Chan, et al.
Toxicologic Pathology|December 23, 2015
Tankyrase Inhibition Causes Reversible Intestinal Toxicity in Mice with a Therapeutic Index < 1Yu Zhong, Paula Katavolos, Trung Nguyen, et al.
General and Comparative Endocrinology|July 13, 2016
Methyltestosterone alters sex determination in the American alligator (Alligator mississippiensis)Christopher M Murray, Michael Easter, Mark Merchant, et al.
Nature Biotechnology|July 9, 2013
Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodiesChristoph Spiess, Mark Merchant, Arthur Huang, et al.
Molecular Systems Biology|June 12, 2013
Network quantification of EGFR signaling unveils potential for targeted combination therapyBertram Klinger, Anja Sieber, Raphaela Fritsche-Guenther, et al.
Molecular Cancer Therapeutics|August 14, 2015
Redesigning a Monospecific Anti-FGFR3 Antibody to Add Selectivity for FGFR2 and Expand Antitumor ActivityYiyuan Yin, Stevan Djakovic, Scot Marsters, et al.
Molecular and Cellular Biology|September 16, 2004
Suppressor of fused regulates Gli activity through a dual binding mechanismMark Merchant, Felix F Vajdos, Mark Ultsch, et al.
Molecular Cancer Therapeutics|November 22, 2013
Nonclinical evaluation of the serum pharmacodynamic biomarkers HGF and shed MET following dosing with the anti-MET monovalent monoclonal antibody onartuzumabElaine Mai, Zhong Zheng, Youjun Chen, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 25, 2010
Preclinical absorption, distribution, metabolism, excretion, and pharmacokinetic-pharmacodynamic modelling of N-(4-(3-((3S,4R)-1-ethyl-3-fluoropiperidine-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-4-yloxy)-3-fluorophenyl)-2-(4-fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxamide, a novel MET kinase inhibitorBianca M Liederer, Leonid M Berezhkovskiy, Brian J Dean, et al.
NPJ Systems Biology and Applications|September 8, 2017
Erratum: Clinical responses to ERK inhibition in <i>BRAF</i><sup>V600E</sup>-mutant colorectal cancer predicted using a computational modelDaniel C Kirouac, Gabriele Schaefer, Jocelyn Chan, et al.
NPJ Systems Biology and Applications|June 27, 2017
Clinical responses to ERK inhibition in <i>BRAF</i><sup>V600E</sup>-mutant colorectal cancer predicted using a computational modelDaniel C Kirouac, Gabriele Schaefer, Jocelyn Chan, et al.
Toxicologic Pathology|December 23, 2015
Tankyrase Inhibition Causes Reversible Intestinal Toxicity in Mice with a Therapeutic Index < 1Yu Zhong, Paula Katavolos, Trung Nguyen, et al.
General and Comparative Endocrinology|July 13, 2016
Methyltestosterone alters sex determination in the American alligator (Alligator mississippiensis)Christopher M Murray, Michael Easter, Mark Merchant, et al.
Nature Biotechnology|July 9, 2013
Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodiesChristoph Spiess, Mark Merchant, Arthur Huang, et al.
Molecular Systems Biology|June 12, 2013
Network quantification of EGFR signaling unveils potential for targeted combination therapyBertram Klinger, Anja Sieber, Raphaela Fritsche-Guenther, et al.
Molecular Cancer Therapeutics|August 14, 2015
Redesigning a Monospecific Anti-FGFR3 Antibody to Add Selectivity for FGFR2 and Expand Antitumor ActivityYiyuan Yin, Stevan Djakovic, Scot Marsters, et al.
Molecular and Cellular Biology|September 16, 2004
Suppressor of fused regulates Gli activity through a dual binding mechanismMark Merchant, Felix F Vajdos, Mark Ultsch, et al.
Molecular Cancer Therapeutics|November 22, 2013
Nonclinical evaluation of the serum pharmacodynamic biomarkers HGF and shed MET following dosing with the anti-MET monovalent monoclonal antibody onartuzumabElaine Mai, Zhong Zheng, Youjun Chen, et al.
Pageof 11